diphenyleneiodonium and paclitaxel

diphenyleneiodonium has been researched along with paclitaxel in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Bastow, KF; Chang, FR; Hwang, TL; Lai, WC; Lee, KH; Morris-Natschke, SL; Nakagawa-Goto, K; Wu, PC; Wu, YC; Yen, CT1
Bastow, KF; Hwang, TL; Lee, KH; Morris-Natschke, SL; Nakagawa-Goto, K; Wu, YC; Yen, CT1
Scaife, RM2

Other Studies

5 other study(ies) available for diphenyleneiodonium and paclitaxel

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Antitumor agents. 271: total synthesis and evaluation of brazilein and analogs as anti-inflammatory and cytotoxic agents.
    Bioorganic & medicinal chemistry letters, 2010, Feb-01, Volume: 20, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzopyrans; Cell Line, Tumor; Cytotoxins; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Humans; Indenes; Neutrophils

2010
Design and synthesis of gambogic acid analogs as potent cytotoxic and anti-inflammatory agents.
    Bioorganic & medicinal chemistry letters, 2012, Jun-15, Volume: 22, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Prenylation; Structure-Activity Relationship; Superoxides; Xanthones

2012
G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:10

    Topics: Animals; Antioxidants; Apoptosis; Aurora Kinase A; Aurora Kinases; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Centrosome; Chromatids; Cyclin B; Cyclin B1; DNA; Down-Regulation; Enzyme Inhibitors; Flavoproteins; Flow Cytometry; G2 Phase; Humans; MAP Kinase Signaling System; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Mitosis; NIH 3T3 Cells; Onium Compounds; Paclitaxel; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Spindle Apparatus; Threonine; Time Factors; Xenopus Proteins

2004
Selective and irreversible cell cycle inhibition by diphenyleneiodonium.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:6

    Topics: Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Shape; Centrosome; Chromatin; Humans; Metaphase; Mitosis; Nocodazole; Onium Compounds; Paclitaxel; Spindle Apparatus

2005